Table: begin end state 1 5 non-cytoplasmic 6 26 transmembrane 27 37 cytoplasmic 38 58 transmembrane 59 68 non-cytoplasmic 69 88 transmembrane 89 115 cytoplasmic 116 135 transmembrane 136 163 non-cytoplasmic 164 185 transmembrane 186 196 cytoplasmic 197 224 transmembrane 225 255 non-cytoplasmic 256 274 transmembrane 275 293 cytoplasmic 294 317 transmembrane 318 341 non-cytoplasmic 342 369 transmembrane 370 384 cytoplasmic 385 409 transmembrane 410 417 non-cytoplasmic 418 442 transmembrane 443 450 cytoplasmic 451 474 transmembrane 475 506 non-cytoplasmic 507 527 transmembrane 528 612 cytoplasmic 613 631 transmembrane 632 1082 non-cytoplasmic
Input: >WP_012470155.1 NCBI__GCF_000020385.1:WP_012470155.1 MTLNILHVTAIAAAYTGLLFLVAWYARRRFEQGRSLVNNPYVYSLSIAVYCTSWTFYGSV GKAATSGIDFLMIYLGPSLVAFSWFFILRRIIRISKENNVSSIADFISLRYGSSQLLGSL ITLIAVLGIMPYIALQIKAVVTSFALVSGVTERTITLPGADSSVILPTGLTLAVILSIFG VIFGARRLPSTERHEGLIAAVAFESVVKLVSLVGVGVFVTWYLFDGFEDILFRFHTQYPL LFERLFTLNTTQGNDVIPSSTMLFLSMGAIILLPRQFHVLVIENADLRHISKAMWLFPTY LFLINLFIMPIALGGILQSGSNIGADYFVISVPLAAGNESMALLAFLGGLSAAAGMVMVE SVAISTMLLNNLFMPVIVRITPKQWFPLLLINLKRVAIFLVVFLGYFYYQAVGDSFMLVN MGLISFLAAMQFLPALLGGLYWPKGNKIGAISGMALGFIIWSYTLLIPSFFAAVPDSPIM RDGLFGQALLKPTALFGLTGMDMWSHALFWSMLFNVGAYLVCSLLISQSDLEKEQVRRFI GKFETERRQVKSAAKRLSKPVTIPQFIGLMGKFIGPEEASQAMTSYLKGRMIDEEIMVPE FELPAMKRFVERTLAASVGAAAAGAIMDSYLSDMGSRMESVYDIFSTVRASLDQSREALY VRLKASEIINRTLDLQTIMDELLQLLLKEFRLDVALIQIRTSSDVPLSVQSYQGCDRRPI NPEHWYLESDPYIKMAMIDQTTHFVNDIKNLQAIIDLSKTTSEGFVSFAHIPIYREGEES LGVLSVYSKSIIGLFTEEFVGLLTSLTGQLAQAARLASEMQAKERERREKEQALLANARV KRDMEIAEQIQLSLLPASPPVLFGIELAGRCYPAAHVGGDYYDFFKRDDHTIDLLIADVS GHSVGAALIMAEVRTLLRAHSSRAVSPSSILGVLNSQLYEDLTRAELFITMFYARYSAAT GRLSYANAGHNKPLIHRQGEQSCIELDAEGLILGIKPSMIFEERSINLQQGDTLLFYTDG IPEATNRTGELLGTGQVCQHLTLQSTLPVDTIADSFFELVKEYSQSTTLQDDVSMVVMKI VA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server